| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | 26,6 k € | — | 86,5 k € | -59.5% | 213,8 k € | ||||||||||||
| Gross margin | -4,8 k € | +40.2% | -8,0 k € | +34.2% | -12,2 k € | -46.1% | -8,3 k € | +11.0% | -9,4 k € | -154.9% | -3,7 k € | +75.0% | -14,7 k € | -0.2% | -14,7 k € | -324.8% | -3,5 k € | -138.0% | 9,1 k € | -36.6% | 14,4 k € | -18.4% | 17,6 k € | -85.6% | 121,8 k € | |
| EBITDA | -5,2 k € | +41.0% | -8,8 k € | +31.9% | -13,0 k € | -42.9% | -9,1 k € | +10.9% | -10,2 k € | -132.6% | -4,4 k € | +71.6% | -15,4 k € | -0.8% | -15,3 k € | -269.1% | -4,1 k € | -150.8% | 8,2 k € | -39.0% | 13,4 k € | -3.5% | 13,9 k € | -88.3% | 118,8 k € | |
| Operating profit | -5,2 k € | +41.0% | -8,8 k € | +33.9% | -13,3 k € | -41.2% | -9,5 k € | +10.5% | -10,6 k € | -121.9% | -4,8 k € | +69.9% | -15,8 k € | -0.8% | -15,7 k € | -246.3% | -4,5 k € | -191.5% | 4,9 k € | -51.4% | 10,2 k € | -0.2% | 10,2 k € | -90.9% | 112,2 k € | |
| Profit/loss | -2,2 k € | +62.4% | -5,9 k € | +40.4% | -9,9 k € | -118.0% | -4,5 k € | +17.5% | -5,5 k € | -283.7% | 3,0 k € | +131.4% | -9,6 k € | +8.1% | -10,4 k € | -1984.8% | 551,5 € | -91.2% | 6,2 k € | +839.8% | 663,9 € | -91.5% | 7,8 k € | -89.8% | 76,6 k € | |
| Equity | 59,2 k € | -3.6% | 61,5 k € | -8.8% | 67,4 k € | -12.8% | 77,3 k € | -5.6% | 81,8 k € | -6.3% | 87,3 k € | +3.6% | 84,3 k € | -10.2% | 93,9 k € | -10.0% | 104,3 k € | +0.5% | 103,7 k € | +6.4% | 97,5 k € | +0.7% | 96,8 k € | +8.8% | 89,0 k € | |
| Total assets | 59,2 k € | -4.4% | 62,0 k € | -10.3% | 69,1 k € | -10.8% | 77,4 k € | -10.2% | 86,2 k € | -4.0% | 89,9 k € | +6.3% | 84,6 k € | -10.0% | 94,0 k € | -11.0% | 105,6 k € | -4.3% | 110,4 k € | +8.4% | 101,8 k € | -36.3% | 159,9 k € | +14.4% | 139,8 k € | |
| Cash | 241,7 € | -29.3% | 341,8 € | -62.6% | 913,0 € | +344.3% | 205,5 € | -59.8% | 510,7 € | +1120.6% | 41,8 € | -91.4% | 484,4 € | -71.4% | 1,7 k € | -93.2% | 24,7 k € | -12.2% | 28,2 k € | -11.7% | 31,9 k € | -77.3% | 140,3 k € | +22.7% | 114,3 k € | |
| Debts | — | 525,7 € | -69.3% | 1,7 k € | +811.3% | 187,9 € | -95.8% | 4,4 k € | +73.7% | 2,6 k € | +915.1% | 251,5 € | +82.2% | 138,1 € | -89.6% | 1,3 k € | -80.1% | 6,7 k € | +52.8% | 4,4 k € | -93.0% | 62,7 k € | +25.0% | 50,2 k € | ||
| Staff | — | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,1 | |||||||||||||
Source: Belgian Official Gazette
Private limited company loss-making in the latest fiscal year. Cash position declining (-29.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
E.J.L. ExAct is a Private limited company incorporated in 2012. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Oostende.
7-day free trial, no credit card required.